APA (7th ed.) Citation

RM, B., LP, G., LA, M., L, H., A, B., A, Z., . . . WH, H. (2011). Exenatide BID Observational Study (ExOS): Results for primary and secondary endpoints of a prospective research study to evaluate the clinical effectiveness of exenatide BID use in patients with type 2 diabetes in a real-world setting. Current Medical Research & Opinion, 27(12), 2335. https://doi.org/10.1185/03007995.2011.628305

Chicago Style (17th ed.) Citation

RM, Bergenstal, et al. "Exenatide BID Observational Study (ExOS): Results for Primary and Secondary Endpoints of a Prospective Research Study to Evaluate the Clinical Effectiveness of Exenatide BID Use in Patients with Type 2 Diabetes in a Real-world Setting." Current Medical Research & Opinion 27, no. 12 (2011): 2335. https://doi.org/10.1185/03007995.2011.628305.

MLA (9th ed.) Citation

RM, Bergenstal, et al. "Exenatide BID Observational Study (ExOS): Results for Primary and Secondary Endpoints of a Prospective Research Study to Evaluate the Clinical Effectiveness of Exenatide BID Use in Patients with Type 2 Diabetes in a Real-world Setting." Current Medical Research & Opinion, vol. 27, no. 12, 2011, p. 2335, https://doi.org/10.1185/03007995.2011.628305.